Another critical example where data from the iCare HOME device is crucial to a Glaucoma patients’ possible treatment path. The speed of information comes into play as data can be instantly available to the physician to make time-sensitive decisions. Thus, benefiting the patient immensely. And again, the ONLY way that this can be accomplished is by using this amazing device. – C EPPERSON, MyEYES.
Excerpt from the article:
Home monitoring can establish pre-treatment IOP patterns that are not evident during in-clinic measurements. Home monitoring can also demonstrate response to treatment more quickly than in-clinic monitoring, and provide more information about nyctohemoral fluctuations than is ascertained by in-clinic tonometry.
This original article was published in the American Journal of Ophthalmology Online Sep 7, 2022.